RARA and metabolic dysfunction-associated steatohepatitis: More importantly, we identified the novel mechanisms that Alisol B attenuated hepatocyte lipid accumulation and lipotoxicity via regulating RARα-PPARγ-CD36 transcriptional cascade, thereby ameliorating the development of NASH.